Nucleic Acids Research, 1981, Vol. 9, No. 18 4709-4719
© 1981
MOLECULAR BIOLOGY |
Aphidicolin inhibits DNA synthesis by DNA polymerase
and isolated nuclei by a similar mechanism
Institute of Medical Biology, University of Tromsø 9000 Tromsø, Norway
Received June 30, 1981.
Aphidicolin is a selective inhibitor of DNA polymerase
. In contrast to earlier reports, the drug was found to inhibit DNA synthesis catalyzed by DNA polymerase
and isolated HeLa cell nuclei by a similar mechanism. For both systems aphidicolin primarily competed with dCTP incorporation. However, the apparent Vmax for dCTP incorporation was reduced by 50-60% at relatively low concentrations of aphidicolin, thus the mechanism of inhibition is complex. Furthermore, a 2-5 fold increase in apparent Km for dTTP was observed in the presence of aphidicolin, but the apparent Km values for dATP and dGTP were essentially unaltered. This, together with additional evidence, suggested that the mechanism of action of aphidicolin involves a strong competition with dCMP incorporation, a weaker competition with dTMP incorporation and very little, if any, competition with dGMP and dAMP incorporation.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
P. J. Masih, D. Kunnev, and T. Melendy Mismatch Repair proteins are recruited to replicating DNA through interaction with Proliferating Cell Nuclear Antigen (PCNA) Nucleic Acids Res., January 17, 2008; 36(1): 67 - 75. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Hassan and P. Cook Visualization of replication sites in unfixed human cells J. Cell Sci., January 6, 1993; 105(2): 541 - 550. [Abstract] [PDF] |
||||

